Pharmacology of thrombolytic drugs (Q39591872)

13 September 2017

1 reference

title

Pharmacology of thrombolytic drugs (English)

1 reference

13 September 2017

1 reference

1 reference

M Verstraete

1

1 reference

13 September 2017

D Collen

series ordinal

2

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 December 1986

1 reference

Journal of the American College of Cardiology

13 September 2017

published in

1 reference

13 September 2017

volume

8

1 reference

13 September 2017

issue

6 Suppl B

1 reference

13 September 2017

page(s)

33B-40B

1 reference

Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The structure of streptokinase. I. Cyanogen bromide fragmentation, amino acid composition and partial amino acid sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Complete amino acid sequence of streptokinase and its homology with serine proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The mechanism of activation of human plasminogen by streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Kinetic mechanism of the activation of human plasminogen by streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The human plasma fibrinolytic system: Regulation and control

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The clearance of heterologous protein from the circulation of normal and immunized man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Thrombolytic Therapy with Streptokinase Using a Standard Dosage Scheme

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Treatment of deep vein thrombosis with streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Low-dose intravascular fibrinolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Guidelines for thrombolytic therapy of deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Current concepts: guidelines for the use of thrombolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

1 reference

7 January 2021

Biological effects of the administration of an equimolar streptokinase-plasminogen complex in man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Fibrinolytic activity of an isolated equimolar human plasmin-streptokinase activator complex in an experimental dog model.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Urokinase an activator of plasminogen from human urine. I. Isolation and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The isolation and characterization of plasminogen activators (urokinase) from human urine.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and Plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The Inhibition of Urokinase by Alpha2-Macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

1 reference

7 January 2021

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Isolation of two variants of native one-chain tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Adaptation of plasminogen activator sequences to known protease structures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Fibrinolysis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Plasminogen activation by tissue activator is accelerated in the presence of fibrin(ogen) cyanogen bromide fragment FCB-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Expression in E. coli of finger-domain lacking tissue-type plasminogen activator with high fibrin affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Enzymatic properties of the one- and two-chain form of tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Evidence for a rapid inhibitor to tissue plasminogen activator in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Improvement of regional myocardial metabolism after coronary thrombolysis induced with tissue-type plasminogen activator or streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Thrombolysis, clot selectivity, and kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

The sulphite precipitation method for fibrinogen measurement; Its use on small samples in the presence of fibrinogen degradation products

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Coronary thrombolysis in dogs with intravenously administered human pro-urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

Coronary thrombolysis with human single-chain, urokinase-type plasminogen activator (pro-urokinase) in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2886%2980005-5

7 January 2021

10.1016/S0735-1097(86)80005-5

Identifiers

DOI

1 reference

13 September 2017

1 reference